Advertisement

The Future of Human Longevity

  • S. Jay Olshansky
  • Bruce A. Carnes
Part of the International Handbooks of Population book series (IHOP, volume 1)

The modern rise in life expectancy is one of humanity’s crowning achievements. After more than 200,000 years of slow but steady increases in life expectancy for anatomically modern people like us (McNeill 1976), a new chapter in the book of human longevity began in the middle of the 19 th century when a quantum leap in duration of life began (Omran 1971). The external forces of mortality (e.g., infectious diseases, predation and accidents) that precluded survival beyond the first few years of life for most people were significantly relaxed as modern humans learned how to insulate themselves from the major hazards of the outside world. As a result, the biological consequences of aging are now a common occurrence for the first time in the history of our species. This longevity benefit, however, was accompanied by a trade-off involving a rise in such fatal diseases as cancer, heart disease, stroke and Alzheimer’s disease, as well as such chronic conditions as sensory impairments, arthritis and dementia.

Keywords

Life Expectancy Mortality Decline Human Longevity Infectious Disease Mortality Human Life Expectancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allard M, Lebre V, Robine JM (1998) The longest life: The 122 extraordinary years of jeanne calment. W.H. Freeman and Co, New YorkGoogle Scholar
  2. Armstrong GL, Conn LA, Pinner RW (1999) Trends in infectious disease mortality in the United States during the 20th century. JAMA 281(1):61–66CrossRefGoogle Scholar
  3. Austad S (1999) Why we age: What science is discovering about the body’s journey through life. John Wiley and Sons, New YorkGoogle Scholar
  4. Bell FC, Miller ML (2002) Life tables for the United States social security area 1900–2100. Actuarial Study No. 116, Social Security Administration, Washington, DCGoogle Scholar
  5. Bender R, Jockel KH, Trautner C, Spraul M, Berger M (1999) Effect of age on excess mortality in obesity. JAMA 281:1498–1504CrossRefGoogle Scholar
  6. Bongaarts J (2006) How long will we live? Popul Dev Rev 32(4):605–628CrossRefGoogle Scholar
  7. Bortz WM (1982) Disuse and aging. JAMA 248(10):1203–1208CrossRefGoogle Scholar
  8. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath, Jr. CW (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097–1105CrossRefGoogle Scholar
  9. Carnes BA (2004) Darwinian bodies in a Lamarckian world. Gerontologist 44:274–279Google Scholar
  10. Carnes BA (2007) Senescence as viewed through the lens of comparative biology. Ann NY Acad Sci 114:14–22CrossRefGoogle Scholar
  11. Carnes BA, Olshansky SJ (1997) A biologically motivated partitioning of mortality. Exp Gerontol 32:615–631CrossRefGoogle Scholar
  12. Carnes BA, Olshansky SJ (2001) Heterogeneity and its biode-mographic implications for longevity and mortality. Exp Gerontol 36:419–430CrossRefGoogle Scholar
  13. Carnes BA, Olshansky SJ, Grahn D (2003) Biological evidence for limits to the duration of life. Biogerontology 4(1):31–45CrossRefGoogle Scholar
  14. Carnes BA, Olshansky SJ, Grahn D (2007) A realist view of aging, mortality, and future longevity. Popul Dev Rev 33(2):367–381CrossRefGoogle Scholar
  15. Carnes BA, Olshansky SJ, Grahn D (1996) Continuing the search for a law of mortality. Popul Dev Rev 22(2):231–264CrossRefGoogle Scholar
  16. Carnes BA, Holden LR, Olshansky SJ, Witten TM. Siegel JS. (2006) Mortality partitions and their relevance to research on senescence. Biogerontology 7:183–198CrossRefGoogle Scholar
  17. Carnes BA, Statts DO, Sonntag, WE (2008) Does senescence give risk to disease? Mech Aging Dev (in press)Google Scholar
  18. Cutler RG, Semsei I (1989) Development, cancer and aging: Possible common mechanisms of action and regulation. J Gerontol: Biol Sci 44(6):25–34Google Scholar
  19. de Grey A (2005) Foreseeable and more distant rejuvenation therapies. In: Rattan S (ed) Aging interventions and therapies, World Scientific, SingaporeGoogle Scholar
  20. de Grey A et al (2002) Time to talk SENS: critiquing the immutability of human aging. Ann NY Acad Sci 959:452–462CrossRefGoogle Scholar
  21. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41(8):3655–3660CrossRefGoogle Scholar
  22. Ebbeling CB, Pawlak DB, Ludwig DS (2002) Childhood obesity: Public-health crisis, common sense cure. Lancet 360:473–482CrossRefGoogle Scholar
  23. Fiatarone MA, Evans WJ (1990) Exercise in the oldest old. Topics Geriatr Rehabil 5(2):63–77Google Scholar
  24. Finch CE, Crimmins EM (2004) Inflammatory exposure and historical changes in human life-spans. Science 305:1736–1739CrossRefGoogle Scholar
  25. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727CrossRefGoogle Scholar
  26. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA 289:187–193CrossRefGoogle Scholar
  27. Freedman DS, Khan LK, Serdula MK, et al (2002) Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 288:1758–1761CrossRefGoogle Scholar
  28. Fries JF (1980) Aging, natural death, and the compression of morbidity. N Engl J Med 303:130–135Google Scholar
  29. Gruman GJ (1966) A history of ideas about the prolongation of life: The evolution of prolongevity hypotheses to 1800. Trans Am Phil Soc 56(9)Google Scholar
  30. Gungor N, Thompson T, Sutton-Tyrrell K, Janosky J, Arslanian S (2005) Early signs of cardiovascular disease in youth with obesity and type 2 Diabetes. Diabetes Care 28:1219–1221CrossRefGoogle Scholar
  31. Hamilton WD (1966) The moulding of senescence by natural selection. J Theor Biol 12:12–45CrossRefGoogle Scholar
  32. Hayflick L (2000) The future of ageing. Nature 408:267–269CrossRefGoogle Scholar
  33. Holliday R (2007) Ageing: The paradox of life. Springer Publishing, New YorkGoogle Scholar
  34. Jee SA, Sull JW, Park J, et al (2006) Body-mass index and mortality in Korean men and women. NEJM 355:779–787CrossRefGoogle Scholar
  35. Karon KM, Fleming PL, Steketee RW, De Cock KM (2001) HIV in the United States at the turn of the century: An epidemic in transition. Am J Public Health 91:1016–1017CrossRefGoogle Scholar
  36. Kirkwood TBL (1977) Evolution of aging. Nature 270:301–304CrossRefGoogle Scholar
  37. Kirkwood T (2003) Time of our lives: the science of human aging. Oxford University Press, OxfordGoogle Scholar
  38. Kirkwood T, Finch C (2000) Change, development and ageing. Oxford University Press, OxfordGoogle Scholar
  39. Kirkwood TBL, Holliday R (1979) The evolution of ageing and longevity. Proc R Soc Lond B Biol Sci 205:531–546CrossRefGoogle Scholar
  40. Kuriyama S (2006) Impact of overweight and obesity on medical care costs, all-cause mortality, and the risk of cancer in Japan. J Epidemiol 16(4):139–144CrossRefGoogle Scholar
  41. Kurzweil R, Grossman T (2004) Fantastic voyage: Live long enough to live forever. Rodale Press, Emmaus, PAGoogle Scholar
  42. Kurzweil R (2005) The singularity is near: When humans transcend biology. Viking Press, New YorkGoogle Scholar
  43. Manton KG, Stallard E, Tolley HD (1991) Limits to human life expectancy. Popul Dev Rev 17(4):603–637CrossRefGoogle Scholar
  44. Manton KG, Stallard E, Corder LS (1995) Changes in morbidity and chronic disability in the us elderly population: Evidence from the 1982, 1984, and 1989 national long term care surveys. J Gerontol B Psychol Sci Soc Sci 50(4):S194–S204Google Scholar
  45. Manuel DG, Schultz SE (2004) Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care 27(2):407–414CrossRefGoogle Scholar
  46. McNeill WH. (1976) Plagues and peoples. Anchor, Garden CityGoogle Scholar
  47. McTigue K, Larson JC, Valoski A, et al (2006) Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 296(1):79–86CrossRefGoogle Scholar
  48. Medawar PB (1952) An unsolved problem of biology. Lewis, LondonGoogle Scholar
  49. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195–2000CrossRefGoogle Scholar
  50. Morgan E (1994) The scars of evolution: What our bodies tell us about human origins. Oxford University Press, OxfordGoogle Scholar
  51. Muennig P, Lubetkin E, Jia H, Franks P (2006) Gender and burden of disease attributable to obesity. AJPH 96(9):1662–1668CrossRefGoogle Scholar
  52. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH (1992) Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327:1350–1355Google Scholar
  53. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529CrossRefGoogle Scholar
  54. National Center for Health Statistics (1999) United States life tables eliminating certain causes of death, 1989–1991, vol 4, No. 1. DHHS (PHS) 99-1150-4Google Scholar
  55. Nemetz PN, Roger VL, Ransom JE, Bailey KR, Leibson CL (2007) Recent trends in the prevalence of coronary disease: A population-based autopsy study of non-natural deaths. Arch Intern Med 261, 264–270Google Scholar
  56. Oeppen J, Vaupel J (2002) Broken limits to life expectancy. Science 296(5570):1029–1031CrossRefGoogle Scholar
  57. Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 288:1728–1732CrossRefGoogle Scholar
  58. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555CrossRefGoogle Scholar
  59. Olshansky SJ, Carnes BA (2001) The quest for immortality. Norton, New YorkGoogle Scholar
  60. Olshansky SJ, Persky V (2007) The canary in the coal mine of coronary Artery Disease. Arch Intern Med 168(3):261CrossRefGoogle Scholar
  61. Olshansky SJ, Carnes BA, Cassel C (1990) In search of methuselah: Estimating the upper limits to human longevity. Science 250:634–640CrossRefGoogle Scholar
  62. Olshansky SJ, Carnes BA, Rogers RA, Smith L (1997) Infectious diseases: New and ancient threats to world health. Popul Bull 52(2):1–58Google Scholar
  63. Olshansky SJ, Carnes BA, Grahn D (1998) Confronting the boundaries of human longevity. Am Sci 86(1):52–61Google Scholar
  64. Olshansky SJ, Rogers RG, Carnes BA, Smith L (2000) Emerging infectious diseases: The fifth stage of the epidemiologic transition? World Health Stat Q 51(2,3,4):207–217Google Scholar
  65. Olshansky SJ, Carnes BA, Butler R (2001) If humans were built to last. Sci Am 284(3):50–55CrossRefGoogle Scholar
  66. Olshansky SJ, Carnes BA, Désesquelles A (2001) Prospects for human longevity. Science 291(5508):1491–1492CrossRefGoogle Scholar
  67. Olshansky SJ, Hayflick L, Carnes BA, et al (2002) Position statement on human aging. Sci Am (June),http://www.sciam.com/agingstatement.cfm(Also published in the J Gerontol: Biol Sci 57A(8):B1–B6)
  68. Olshansky SJ, Passaro D, Hershow R, Layden J, Carnes, BA, Brody J, Hayflick L, Butler, RN, Allison, DB, Ludwig, DS. (2005) A potential decline in life expectancy in the United States in the 21st century. New Engl J Med 352:1103–1110CrossRefGoogle Scholar
  69. Olshansky SJ, Perry D, Miller RA, Butler RN (2006) In pursuit of the longevity dividend. Scientist 20(3):28–36Google Scholar
  70. Omran A. (1971) The epidemiologic transition: A theory of the epidemiology of population change. Milbank Mem Fund Q 49:509–538CrossRefGoogle Scholar
  71. Osmon S, Warren D, Seiler SM, Shannon W, Fraser VJ, Kollef MH (2003) The influence of infection on hospital mortality for patients requiring greater than 48 hours of intensive care. Chest 124(3):1021–1029CrossRefGoogle Scholar
  72. Schwimmer JB, Burwinkle TM, Varni JW (2003) Health-related quality of life of severely obese children and adolescents. JAMA 289:1813–1819CrossRefGoogle Scholar
  73. Shock N. (1957) Age changes in some physiologic processes. Geriatrics 12:40–48Google Scholar
  74. Stearns SC (1992) The Evolution of life histories. Oxford University Press, New YorkGoogle Scholar
  75. Thompson DW (1942) On growth and form. Dover Publications, New YorkGoogle Scholar
  76. Tuljapurkar S, Li N, Boe C (2000) A universal pattern of mortality decline in G7 countries. Nature 405:789–792CrossRefGoogle Scholar
  77. United Nations (2003) The impact of AIDS. Population Division, ESA/P/WP.185, New YorkGoogle Scholar
  78. Van Dam RM, Willett WC, Manson JE, Hu FB (2006) The relationship between overweight in adolescence and premature death in women. Ann Intern Med 145:91–97Google Scholar
  79. Vaupel J (1997) Trajectories of mortality at advanced ages. In: Wachter K, Finch C, (ed) Between Zeus and the salmon. National Academy Press, Washington, DC, pp 17–37Google Scholar
  80. Warner H et al (2005) Science fact and the SENS agenda: What can we reasonably expect from ageing research? EMBO Rep 6:1006–1008. Doi: 10.1038/sj.embor.7400555CrossRefGoogle Scholar
  81. Wearing SC, Hennig EM, Byrne NM, Steele JR, Hills AP (2006) Musculoskeletal disorders associated with obesity: A biome-chanical perspective. Obes Rev 7:239–250CrossRefGoogle Scholar
  82. Weismann A (1891) Essays upon heredity and kindred biological problems. Clarendon Press, OxfordGoogle Scholar
  83. Williams GC (1957) Pleiotropy, natural selection and the evolution of senescence. Evolution 11:398–411CrossRefGoogle Scholar
  84. Wilmoth J (1997) In search of limits. In: Wachter K, Finch C, (ed) Between Zeus and the salmon, Washington, DC, National Academy Press, pp 38–64Google Scholar
  85. Wilmoth J (1998) The future of human longevity: A demographer’s perspective. Science 280:395–397CrossRefGoogle Scholar
  86. Wilmoth J (2001) How long can we live? Science debate;http://www.sciencemag.org/cgi/eletters/291/5508/1491
  87. Wilmoth JR, Deegan LJ, Lundstrom H, Horiuchi S (2000) Increase of maximum life-span in Sweden: 1861–1999. Science 289:2366–2368CrossRefGoogle Scholar
  88. World Health Organization (1999) Influenza pandemic plan. The role of WHO and guidelines for national and regional planning. WHO/CDS/CSR/EDC/99.1Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • S. Jay Olshansky
    • 1
  • Bruce A. Carnes
    • 2
  1. 1.Division of Epidemiology and BiostatisticsSchool of Public Health University of Illinois at ChicagoChicagoUSA
  2. 2.Rutgers UniversityNews BrunswickUSA

Personalised recommendations